Experts say Aussie melanoma patients are being subjected to outdated surgery

2GB Weekends

Content provided by Nine Radio. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Nine Radio or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

2M ago 4:49

MP3•Episode home

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on August 11, 2024 04:11 (3d ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Two Aussie melanoma experts are saying patients shouldn’t be undergoing a commonon diagnostic test called a “sentinel lymph node biopsies” (SLNB) on patient’s patients’ lymph glands, particularly on those under 40 years and over 60 years of age.

They say the results are not an accurate predictor of mortality and that many patients are being mismanaged, with potential side effects such as nerve damage.

Their findings, which now have the backing of many in the international medical community, say that patients should instead use a BAUSS score, which they say is more accurate and less invasive.

Luke Grant chats with one of the experts, Professor Anthony Dixon of the Global Melanoma Initiative, about why the BAUSS is a better indicator and if this is how Luke should have had his melanoma treated.

See omnystudio.com/listener for privacy information.

130 episodes

#Business #Radio 2GB #News and Entertainment #Entertainment #Chris Smith